The Institute for Microbial Biotechnology and Metagenomics (IMBM) is a leading research unit based within the Department of Biotechnology at the University of the Western Cape (UWC). Our research employs culture-based approaches as well as cutting edge ”omics” strategies to study microbiomes, and identify novel biosynthetic gene clusters and metabolites. The Institute focuses on the research and development of novel, high-value natural products for the pharmaceutical, cosmeceutical, food & beverage and agricultural industries, as well as products for industrial processes.
The absence of an appropriate biocatalyst has been an impeding factor in many biotechnologies, and thus there is an urgent need for biotechnology innovation. Metagenomics has for almost two decades promised to deliver these biocatalysts, but due to several limitations it has not achieved all that it promised to. We have shown the proof of concept for a highly innovative, novel and powerful technology to take metagenomics to a new level, which represents a paradigm shift in the way that functional metagenomic screening is conducted. The further development of this technology innovation will be the focus of this project, and is expected to result in accelerated discovery of novel enzymes, bioactivities and organisms with enormous commercializable potential in a number of (bio)technology sectors.
Applicants must have completed a PhD degree within no more than 5 years in a foundational discipline relevant to the topic. Experience in metagenomics and/or single cell genomics is required. Applicants should have a strong publication record, interpersonal skills, project management experience, and be able to effectively conduct research as part of a multi-disciplinary team.
The candidate will be under the supervision of Prof. Marla Trindade who holds a DST/NRF Research Chair in Microbial Genomics. Applicants are to submit their CV and covering letter to [email protected].